Literature DB >> 33215740

Site-specific ubiquitination of the E3 ligase HOIP regulates apoptosis and immune signaling.

Lilian M Fennell1, Carlos Gomez Diaz1, Luiza Deszcz1, Anoop Kavirayani2, David Hoffmann1, Kota Yanagitani3, Alexander Schleiffer1,4, Karl Mechtler1,4, Astrid Hagelkruys1, Josef Penninger1,5, Fumiyo Ikeda1,3.   

Abstract

HOIP, the catalytic component of the linear ubiquitin chain assembly complex (LUBAC), is a critical regulator of inflammation. However, how HOIP itself is regulated to control inflammatory responses is unclear. Here, we discover that site-specific ubiquitination of K784 within human HOIP promotes tumor necrosis factor (TNF)-induced inflammatory signaling. A HOIP K784R mutant is catalytically active but shows reduced induction of an NF-κB reporter relative to wild-type HOIP. HOIP K784 is evolutionarily conserved, equivalent to HOIP K778 in mice. We generated HoipK778R/K778R knock-in mice, which show no overt developmental phenotypes; however, in response to TNF, HoipK778R/K778R mouse embryonic fibroblasts display mildly suppressed NF-κB activation and increased apoptotic markers. On the other hand, HOIP K778R enhances the TNF-induced formation of TNFR complex II and an interaction between TNFR complex II and LUBAC. Loss of the LUBAC component SHARPIN leads to embryonic lethality in HoipK778R/K778R mice, which is rescued by knockout of TNFR1. We propose that site-specific ubiquitination of HOIP regulates a LUBAC-dependent switch between survival and apoptosis in TNF signaling.
© 2020 The Authors.

Entities:  

Keywords:  HOIP E3 ligase; TNF; apoptosis; linear ubiquitination; skin inflammation

Mesh:

Substances:

Year:  2020        PMID: 33215740      PMCID: PMC7737615          DOI: 10.15252/embj.2019103303

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   14.012


  69 in total

1.  Regulation of T cell development by the deubiquitinating enzyme CYLD.

Authors:  William W Reiley; Minying Zhang; Wei Jin; Mandy Losiewicz; Keri B Donohue; Christopher C Norbury; Shao-Cong Sun
Journal:  Nat Immunol       Date:  2006-02-26       Impact factor: 25.606

2.  apQuant: Accurate Label-Free Quantification by Quality Filtering.

Authors:  Johannes Doblmann; Frederico Dusberger; Richard Imre; Otto Hudecz; Florian Stanek; Karl Mechtler; Gerhard Dürnberger
Journal:  J Proteome Res       Date:  2018-11-02       Impact factor: 4.466

3.  SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex.

Authors:  Fuminori Tokunaga; Tomoko Nakagawa; Masaki Nakahara; Yasushi Saeki; Masami Taniguchi; Shin-ichi Sakata; Keiji Tanaka; Hiroyasu Nakano; Kazuhiro Iwai
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

4.  Integrated proteomic analysis of post-translational modifications by serial enrichment.

Authors:  Philipp Mertins; Jana W Qiao; Jinal Patel; Namrata D Udeshi; Karl R Clauser; D R Mani; Michael W Burgess; Michael A Gillette; Jacob D Jaffe; Steven A Carr
Journal:  Nat Methods       Date:  2013-06-09       Impact factor: 28.547

5.  One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

Authors:  Haoyi Wang; Hui Yang; Chikdu S Shivalila; Meelad M Dawlaty; Albert W Cheng; Feng Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2013-05-02       Impact factor: 41.582

Review 6.  Ubiquitin-Mediated Regulation of Cell Death, Inflammation, and Defense of Homeostasis.

Authors:  Pascal Meier; Otto Morris; Meike Broemer
Journal:  Curr Top Dev Biol       Date:  2015-09-11       Impact factor: 4.897

7.  Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis.

Authors:  Snehlata Kumari; Younes Redouane; Jaime Lopez-Mosqueda; Ryoko Shiraishi; Malgorzata Romanowska; Stefan Lutzmayer; Jan Kuiper; Conception Martinez; Ivan Dikic; Manolis Pasparakis; Fumiyo Ikeda
Journal:  Elife       Date:  2014-12-02       Impact factor: 8.140

Review 8.  Linear ubiquitination signals in adaptive immune responses.

Authors:  Fumiyo Ikeda
Journal:  Immunol Rev       Date:  2015-07       Impact factor: 12.988

9.  Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency.

Authors:  Bertrand Boisson; Emmanuel Laplantine; Carolina Prando; Silvia Giliani; Elisabeth Israelsson; Zhaohui Xu; Avinash Abhyankar; Laura Israël; Giraldina Trevejo-Nunez; Dusan Bogunovic; Alma-Martina Cepika; Donna MacDuff; Maya Chrabieh; Marjorie Hubeau; Fanny Bajolle; Marianne Debré; Evelina Mazzolari; Donatella Vairo; Fabrice Agou; Herbert W Virgin; Xavier Bossuyt; Caroline Rambaud; Fabio Facchetti; Damien Bonnet; Pierre Quartier; Jean-Christophe Fournet; Virginia Pascual; Damien Chaussabel; Luigi D Notarangelo; Anne Puel; Alain Israël; Jean-Laurent Casanova; Capucine Picard
Journal:  Nat Immunol       Date:  2012-10-28       Impact factor: 25.606

10.  LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis.

Authors:  Nieves Peltzer; Maurice Darding; Antonella Montinaro; Peter Draber; Helena Draberova; Sebastian Kupka; Eva Rieser; Amanda Fisher; Ciaran Hutchinson; Lucia Taraborrelli; Torsten Hartwig; Elodie Lafont; Tobias L Haas; Yutaka Shimizu; Charlotta Böiers; Aida Sarr; James Rickard; Silvia Alvarez-Diaz; Michael T Ashworth; Allison Beal; Tariq Enver; John Bertin; William Kaiser; Andreas Strasser; John Silke; Philippe Bouillet; Henning Walczak
Journal:  Nature       Date:  2018-04-25       Impact factor: 49.962

View more
  2 in total

Review 1.  Site-specific ubiquitination: Deconstructing the degradation tag.

Authors:  Emma C Carroll; Susan Marqusee
Journal:  Curr Opin Struct Biol       Date:  2022-03-02       Impact factor: 7.786

2.  The ubiquitin ligase HOIL-1L regulates immune responses by interacting with linear ubiquitin chains.

Authors:  Carlos Gomez-Diaz; Gustav Jonsson; Katrin Schodl; Luiza Deszcz; Annika Bestehorn; Kevin Eislmayr; Jorge Almagro; Anoop Kavirayani; Mayu Seida; Lilian M Fennell; Astrid Hagelkruys; Pavel Kovarik; Josef M Penninger; Fumiyo Ikeda
Journal:  iScience       Date:  2021-10-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.